Paper835014
Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors.
Bernacki RJ and 1 other. Science, 1977. Cited by 145 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors. Papers, record 835014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/835014
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mammary Neoplasms, Experimental | Major topic |
| Neoplasm Metastasis | Major topic |
| Sialic Acids | Major topic |
| Sialyltransferases | Major topic |
| Transferases | Major topic |
| Animals | |
| Female | |
| Liver | |
| Methylcholanthrene | |
| Microsomes | |
| Rats | |
| Time Factors |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 145 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37171590 | Computational studies on glycosaminoglycan recognition of sialyl transferases. | Glycobiology | 2023 | https://conductscience.org/library/papers/37171590 | PubMed |
| 34577144 | Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives. | Molecules | 2021 | https://conductscience.org/library/papers/34577144 | PubMed |
| 34244548 | Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/34244548 | PubMed |
| 31408003 | B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism. | Elife | 2019 | https://conductscience.org/library/papers/31408003 | PubMed |
| 29680984 | Serum sialylation changes in cancer. | Glycoconj J | 2018 | https://conductscience.org/library/papers/29680984 | PubMed |
| 28706639 | A sialic acid-targeted near-infrared theranostic for signal activation based intraoperative tumor ablation. | Chem Sci | 2015 | https://conductscience.org/library/papers/28706639 | PubMed |
| 24594619 | Hierarchical partitioning of metazoan protein conservation profiles provides new functional insights. | PLoS One | 2014 | https://conductscience.org/library/papers/24594619 | PubMed |
| 24550397 | Platelets support extracellular sialylation by supplying the sugar donor substrate. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24550397 | PubMed |
| 22449099 | Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells. | Radiat Oncol | 2012 | https://conductscience.org/library/papers/22449099 | PubMed |
| 9613821 | New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay. | Glycoconj J | 1998 | https://conductscience.org/library/papers/9613821 | PubMed |
| 9298713 | A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients. | J Bioenerg Biomembr | 1997 | https://conductscience.org/library/papers/9298713 | PubMed |
| 7275141 | Quantitation of human mammary epithelial antigens in cells cultured from normal and cancerous breast tissues. | In Vitro | 1981 | https://conductscience.org/library/papers/7275141 | PubMed |
| 6897621 | Manganese potentiation of autologous anti-Meth A tumor vaccines. A developmental study. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6897621 | PubMed |
| 6616079 | Post-operative serum sialyltransferase levels and prognosis in breast cancer. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6616079 | PubMed |
| 6425833 | Characterization of monoclonal antibodies to serum galactosyltransferase. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6425833 | PubMed |
| 6240149 | Prostatic origin of fucosyl transferase in human seminal plasma--a study on healthy controls and on men with infertility or with prostatic cancer. | Urol Res | 1984 | https://conductscience.org/library/papers/6240149 | PubMed |
| 6156910 | Elevated glycosyltransferase activities in infected or traumatized hosts: nonspecific response to inflammation. | Infect Immun | 1980 | https://conductscience.org/library/papers/6156910 | PubMed |
| 4005138 | Analysis of mammary tumour cell metastasis and release of bound n-acetylneuraminic acid. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4005138 | PubMed |
| 3978247 | Breast cancer markers: comparison between sialyltransferase and human mammary epithelial antigens (HME-Ags) for the detection of human breast tumors grafted in nude mice. | Breast Cancer Res Treat | 1985 | https://conductscience.org/library/papers/3978247 | PubMed |
| 2825636 | Cell surface expression of 4 beta-galactosyltransferase accompanies rat parotid gland hypertrophy induced by changes in diet. | Biochem J | 1987 | https://conductscience.org/library/papers/2825636 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/835014
GET https://conductscience.org/api/papers/v1/835014/cited_by?page=2